Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Drug Eluting Guidewire Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4662709
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 140 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Drug Eluting Guidewire market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Drug eluting guidewire is a medical device that combines the traditional guiding function of the guidewire with the drug elution technology. It mainly consists of two parts: the guidewire body and the drug coating. The guidewire body is usually made of highly elastic materials (such as stainless steel, nickel-titanium alloy, etc.), has good flexibility and pushability, and can smoothly pass through blood vessels or other lumens to reach the lesion site. The drug coating is coated on the surface or specific parts of the guidewire, and these coatings contain therapeutic drugs. During interventional treatment, after the drug eluting guidewire is sent to the lesion site, the drug coating on its surface will gradually contact the blood or tissue and release the drug. These drugs can directly act on the lesion tissue and exert their therapeutic effects, such as inhibiting the proliferation of vascular smooth muscle cells, reducing inflammatory reactions, preventing thrombosis and restenosis, etc. This local administration method has higher targeting and lower side effects than systemic administration.
This report is a detailed and comprehensive analysis for global Drug Eluting Guidewire market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Eluting Guidewire market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drug Eluting Guidewire market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drug Eluting Guidewire market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Drug Eluting Guidewire market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Eluting Guidewire
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Eluting Guidewire market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, Medtronic, Svelte Medical Systems, Terumo, Micro-Port Scientific, Aachen Resonance, Biosensors International, Biotronik, Cardionovum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drug Eluting Guidewire market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Drug-coated Guidewire
Other
Market segment by Application
Coronary Intervention
Neurointervention
Other
Major players covered
Abbott
Boston Scientific
Medtronic
Svelte Medical Systems
Terumo
Micro-Port Scientific
Aachen Resonance
Biosensors International
Biotronik
Cardionovum
eucatech
Eurocor
iVascular
Laborie Medical Technologies
Lepu Medical
Spectranetics
Cook Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Guidewire product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Guidewire, with price, sales quantity, revenue, and global market share of Drug Eluting Guidewire from 2020 to 2025.
Chapter 3, the Drug Eluting Guidewire competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Guidewire breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Drug Eluting Guidewire market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Guidewire.
Chapter 14 and 15, to describe Drug Eluting Guidewire sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug Eluting Guidewire Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Drug-coated Guidewire
    • 1.3.3 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Drug Eluting Guidewire Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Coronary Intervention
    • 1.4.3 Neurointervention
    • 1.4.4 Other
  • 1.5 Global Drug Eluting Guidewire Market Size & Forecast
    • 1.5.1 Global Drug Eluting Guidewire Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Drug Eluting Guidewire Sales Quantity (2020-2031)
    • 1.5.3 Global Drug Eluting Guidewire Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Drug Eluting Guidewire Product and Services
    • 2.1.4 Abbott Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Drug Eluting Guidewire Product and Services
    • 2.2.4 Boston Scientific Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 Medtronic
    • 2.3.1 Medtronic Details
    • 2.3.2 Medtronic Major Business
    • 2.3.3 Medtronic Drug Eluting Guidewire Product and Services
    • 2.3.4 Medtronic Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Medtronic Recent Developments/Updates
  • 2.4 Svelte Medical Systems
    • 2.4.1 Svelte Medical Systems Details
    • 2.4.2 Svelte Medical Systems Major Business
    • 2.4.3 Svelte Medical Systems Drug Eluting Guidewire Product and Services
    • 2.4.4 Svelte Medical Systems Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Svelte Medical Systems Recent Developments/Updates
  • 2.5 Terumo
    • 2.5.1 Terumo Details
    • 2.5.2 Terumo Major Business
    • 2.5.3 Terumo Drug Eluting Guidewire Product and Services
    • 2.5.4 Terumo Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Terumo Recent Developments/Updates
  • 2.6 Micro-Port Scientific
    • 2.6.1 Micro-Port Scientific Details
    • 2.6.2 Micro-Port Scientific Major Business
    • 2.6.3 Micro-Port Scientific Drug Eluting Guidewire Product and Services
    • 2.6.4 Micro-Port Scientific Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Micro-Port Scientific Recent Developments/Updates
  • 2.7 Aachen Resonance
    • 2.7.1 Aachen Resonance Details
    • 2.7.2 Aachen Resonance Major Business
    • 2.7.3 Aachen Resonance Drug Eluting Guidewire Product and Services
    • 2.7.4 Aachen Resonance Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Aachen Resonance Recent Developments/Updates
  • 2.8 Biosensors International
    • 2.8.1 Biosensors International Details
    • 2.8.2 Biosensors International Major Business
    • 2.8.3 Biosensors International Drug Eluting Guidewire Product and Services
    • 2.8.4 Biosensors International Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Biosensors International Recent Developments/Updates
  • 2.9 Biotronik
    • 2.9.1 Biotronik Details
    • 2.9.2 Biotronik Major Business
    • 2.9.3 Biotronik Drug Eluting Guidewire Product and Services
    • 2.9.4 Biotronik Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Biotronik Recent Developments/Updates
  • 2.10 Cardionovum
    • 2.10.1 Cardionovum Details
    • 2.10.2 Cardionovum Major Business
    • 2.10.3 Cardionovum Drug Eluting Guidewire Product and Services
    • 2.10.4 Cardionovum Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Cardionovum Recent Developments/Updates
  • 2.11 eucatech
    • 2.11.1 eucatech Details
    • 2.11.2 eucatech Major Business
    • 2.11.3 eucatech Drug Eluting Guidewire Product and Services
    • 2.11.4 eucatech Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 eucatech Recent Developments/Updates
  • 2.12 Eurocor
    • 2.12.1 Eurocor Details
    • 2.12.2 Eurocor Major Business
    • 2.12.3 Eurocor Drug Eluting Guidewire Product and Services
    • 2.12.4 Eurocor Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Eurocor Recent Developments/Updates
  • 2.13 iVascular
    • 2.13.1 iVascular Details
    • 2.13.2 iVascular Major Business
    • 2.13.3 iVascular Drug Eluting Guidewire Product and Services
    • 2.13.4 iVascular Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 iVascular Recent Developments/Updates
  • 2.14 Laborie Medical Technologies
    • 2.14.1 Laborie Medical Technologies Details
    • 2.14.2 Laborie Medical Technologies Major Business
    • 2.14.3 Laborie Medical Technologies Drug Eluting Guidewire Product and Services
    • 2.14.4 Laborie Medical Technologies Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Laborie Medical Technologies Recent Developments/Updates
  • 2.15 Lepu Medical
    • 2.15.1 Lepu Medical Details
    • 2.15.2 Lepu Medical Major Business
    • 2.15.3 Lepu Medical Drug Eluting Guidewire Product and Services
    • 2.15.4 Lepu Medical Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Lepu Medical Recent Developments/Updates
  • 2.16 Spectranetics
    • 2.16.1 Spectranetics Details
    • 2.16.2 Spectranetics Major Business
    • 2.16.3 Spectranetics Drug Eluting Guidewire Product and Services
    • 2.16.4 Spectranetics Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Spectranetics Recent Developments/Updates
  • 2.17 Cook Medical
    • 2.17.1 Cook Medical Details
    • 2.17.2 Cook Medical Major Business
    • 2.17.3 Cook Medical Drug Eluting Guidewire Product and Services
    • 2.17.4 Cook Medical Drug Eluting Guidewire Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Cook Medical Recent Developments/Updates

3 Competitive Environment: Drug Eluting Guidewire by Manufacturer

  • 3.1 Global Drug Eluting Guidewire Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Drug Eluting Guidewire Revenue by Manufacturer (2020-2025)
  • 3.3 Global Drug Eluting Guidewire Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Drug Eluting Guidewire by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Drug Eluting Guidewire Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Drug Eluting Guidewire Manufacturer Market Share in 2024
  • 3.5 Drug Eluting Guidewire Market: Overall Company Footprint Analysis
    • 3.5.1 Drug Eluting Guidewire Market: Region Footprint
    • 3.5.2 Drug Eluting Guidewire Market: Company Product Type Footprint
    • 3.5.3 Drug Eluting Guidewire Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug Eluting Guidewire Market Size by Region
    • 4.1.1 Global Drug Eluting Guidewire Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Drug Eluting Guidewire Consumption Value by Region (2020-2031)
    • 4.1.3 Global Drug Eluting Guidewire Average Price by Region (2020-2031)
  • 4.2 North America Drug Eluting Guidewire Consumption Value (2020-2031)
  • 4.3 Europe Drug Eluting Guidewire Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Drug Eluting Guidewire Consumption Value (2020-2031)
  • 4.5 South America Drug Eluting Guidewire Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Drug Eluting Guidewire Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 5.2 Global Drug Eluting Guidewire Consumption Value by Type (2020-2031)
  • 5.3 Global Drug Eluting Guidewire Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 6.2 Global Drug Eluting Guidewire Consumption Value by Application (2020-2031)
  • 6.3 Global Drug Eluting Guidewire Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 7.2 North America Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 7.3 North America Drug Eluting Guidewire Market Size by Country
    • 7.3.1 North America Drug Eluting Guidewire Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Drug Eluting Guidewire Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 8.2 Europe Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 8.3 Europe Drug Eluting Guidewire Market Size by Country
    • 8.3.1 Europe Drug Eluting Guidewire Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Drug Eluting Guidewire Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Drug Eluting Guidewire Market Size by Region
    • 9.3.1 Asia-Pacific Drug Eluting Guidewire Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Drug Eluting Guidewire Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 10.2 South America Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 10.3 South America Drug Eluting Guidewire Market Size by Country
    • 10.3.1 South America Drug Eluting Guidewire Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Drug Eluting Guidewire Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug Eluting Guidewire Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Drug Eluting Guidewire Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Drug Eluting Guidewire Market Size by Country
    • 11.3.1 Middle East & Africa Drug Eluting Guidewire Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Drug Eluting Guidewire Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Drug Eluting Guidewire Market Drivers
  • 12.2 Drug Eluting Guidewire Market Restraints
  • 12.3 Drug Eluting Guidewire Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug Eluting Guidewire and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug Eluting Guidewire
  • 13.3 Drug Eluting Guidewire Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug Eluting Guidewire Typical Distributors
  • 14.3 Drug Eluting Guidewire Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Drug Eluting Guidewire. Industry analysis & Market Report on Drug Eluting Guidewire is a syndicated market report, published as Global Drug Eluting Guidewire Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Drug Eluting Guidewire market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo